SAVA vs. ALZN
Compare and contrast key facts about Cassava Sciences, Inc. (SAVA) and Alzamend Neuro, Inc. (ALZN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SAVA or ALZN.
Key characteristics
| SAVA | ALZN | |
|---|---|---|
| YTD Return | -8.40% | -43.26% |
| 1Y Return | -22.10% | -93.28% |
| Sharpe Ratio | -0.35 | -0.99 |
| Daily Std Dev | 74.68% | 94.42% |
| Max Drawdown | -99.18% | -99.75% |
| Current Drawdown | -84.76% | -99.75% |
Fundamentals
| SAVA | ALZN | |
|---|---|---|
| Market Cap | $874.86M | $3.73M |
| EPS | -$2.32 | -$1.82 |
| PEG Ratio | 20.44 | 1.17 |
| Revenue (TTM) | $0.00 | $0.00 |
| Gross Profit (TTM) | -$68.03M | $0.00 |
| EBITDA (TTM) | -$104.43M | -$12.35M |
Correlation
The correlation between SAVA and ALZN is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SAVA vs. ALZN - Performance Comparison
In the year-to-date period, SAVA achieves a -8.40% return, which is significantly higher than ALZN's -43.26% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SAVA vs. ALZN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cassava Sciences, Inc. (SAVA) and Alzamend Neuro, Inc. (ALZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SAVA vs. ALZN - Dividend Comparison
Neither SAVA nor ALZN has paid dividends to shareholders.
Drawdowns
SAVA vs. ALZN - Drawdown Comparison
The maximum SAVA drawdown since its inception was -99.18%, roughly equal to the maximum ALZN drawdown of -99.75%. Use the drawdown chart below to compare losses from any high point for SAVA and ALZN. For additional features, visit the drawdowns tool.
Volatility
SAVA vs. ALZN - Volatility Comparison
The current volatility for Cassava Sciences, Inc. (SAVA) is 18.59%, while Alzamend Neuro, Inc. (ALZN) has a volatility of 31.99%. This indicates that SAVA experiences smaller price fluctuations and is considered to be less risky than ALZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SAVA vs. ALZN - Financials Comparison
This section allows you to compare key financial metrics between Cassava Sciences, Inc. and Alzamend Neuro, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities